Nivolumab improves the proportion of lung cancer patients alive after more than a year
Patients with a type of lung cancer called non-squamous non-small cell lung cancer (non-SQ NSCLC) have limited treatment options and a dismal prognosis once their disease has advanced and initial treatment with platinum-based ...
Sep 28, 2015